Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 724-728

  Li, Lin ^a   Low, Min Yong ^a,b   Ge, Xiaowei ^b   Bloodworth, Bosco C ^b   Koh, Hwee Ling ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b HEALTH SCIENCES AUTHORITY   (Singapore)

Author keywords

Adulteration; Dapoxetine; Health supplement; Premature ejaculation; Sexual performance enhancement

Indexed keywords

DAPOXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DETERMINATION; DRUG INDICATION; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MELTING POINT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREMATURE EJACULATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SINGAPORE; ULTRAVIOLET SPECTROSCOPY;

BENZYLAMINES; CHEMISTRY, PHARMACEUTICAL; DIETARY SUPPLEMENTS; DRUG CONTAMINATION; ERECTILE DYSFUNCTION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; NAPHTHALENES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET; TANDEM MASS SPECTROMETRY; TEMPERATURE;

EID: 70349183541     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.06.005     Document Type: Article

References (16)

1. McMahon C.G., Abdo C., Incrocci L., Perelman M., Rowland D., Waldinger M., and Xin Z.C. J. Sex. Med. 1 (2004) 58-65
2. Vardi Y., McMahon C.G., Waldinger M.D., Rubio-Aurioles E., and Rabinowitz D. J. Sex. Med. 5 (2008) 1546-1551
3. Giuliano F., and Hellstrom W.J. BJU Int. 102 (2008) 668-675
4. Shabsigh R., Patrick D.L., Rowland D.L., Bull S.A., Tesfaye F., and Rothman M. BJU Int. 102 (2008) 824-828
5. Kendirci M., Salem E., and Hellstrom W.J. Ther. Clin. Risk. Manag. 3 (2007) 277-289
6. Buvat J., Tesfaye F., Rothman M., Rivas D.A., and Giuliano F. Eur. Urol. 55 (2009) 957-968
7. Kaufman J.M., Rosen R.C., Mudumbi R.V., Tesfaye F., Hashmonay R., and Rivas D. BJU Int. 103 (2009) 651-658
8. Wang W.F., Wang Y., Minhas S., and Ralph D.J. Int. J. Urol. 14 (2007) 331-335
9. Sun X.Z., Deng C.H., and Dai Y.P. Zhonghua Nan Ke Xue 13 (2007) 610-612
10. Mattos R.M., Marmo Lucon A., and Srougi M. Urol. Int. 80 (2008) 162-165
11. Singh S., Prasad B., Savaliya A.A., Shah R.P., Gohil V.M., and Kaur A. Trends Anal. Chem. 28 (2009) 13-28
12. Zou P., Hou P., Oh S.S., Chong Y.M., Bloodworth B.C., Low M.Y., and Koh H.L. J. Pharm. Biomed. Anal. 47 (2008) 279-284
13. Zou P., Hou P., Oh S.S., Ge X., Bloodworth B.C., Low M.Y., and Koh H.L. J. Pharm. Biomed. Anal. 47 (2008) 255-259
14. Ge X.W., Low M.Y., Zou P., Lin L., Yin S.O., Bloodworth B.C., and Koh H.L. J. Pharm. Biomed. Anal. 48 (2008) 1070-1075
15. Siddiqui S.A., and Srinivasan K.V. Tetrahedron Asymmetry 18 (2007) 2099-2103
16. Torre O., Gotor-Fernandez V., and Gotor V. Tetrahedron Asymmetry 17 (2006) 860-866